Recall Register

Food, drugs, devices › Roche Molecular Systems, Inc.

Device recall: The cobas z 480 analyzer including dedicated software for IVD use is a plate-based automated amplification and detection

FDA enforcement event 86879 · Class II · initiated 19 Nov 2020 · status Terminated · terminated 10 Aug 2023

DeviceVoluntary: Firm initiated1 product recordBranchburg, NJ

FDA enforcement event 86879 is a device recall by Roche Molecular Systems, Inc. of Branchburg, NJ, initiated 19 Nov 2020 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 93% of the 916 device enforcement events initiated in 2020 carry the same class.

Status: Terminated, terminated 10 Aug 2023. Initiation: voluntary: firm initiated. Roche Molecular Systems, Inc. has 30 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Roche Molecular Systems, Inc., Branchburg, NJ.

Reason for recall

"Dirty Lens May Cause Invalid or False Positive Results"

Distribution

"Worldwide distribution - US Nationwide distribution and the countries of Canada, Germany, Italy, Spain, United Kingdom, France, Austria, Turkey, Belgium, Poland, Portugal, Greece, Netherlands,…"

Product records

Recall numberProductQuantityClassStatusReport date
Z-0846-2021The cobas z 480 analyzer including dedicated software for IVD use is a plate-based automated amplification and detection system for nucleic acids. The analyzer is intended to be used as an in-vitro diagnostic or screening system providing real time PCR amplification and detection for human samples within the system.…597 units US; 3411 units OUSClass IITerminated20 Jan 2021

Context

93%of 2020 device events are Class II916 events that year
1product record in this eventfirm median: 1
30events on this register for the firm

Other enforcement events for Roche Molecular Systems, Inc.

InitiatedProduct (first record)TypeClassRecords
21 Dec 2022cobas SARS-CoV-2 & Influenza A/B Qualitative assay for use on the cobas 6800/8800 Systems; Material number 09233474190DeviceClass II3
8 Sep 2022cobas 5800 instrument, Material No. 08707464001. Used for automated Polymerase Chain Reaction (PCR) based Nucleic Acid TDeviceClass II1
16 Nov 2021cobas LiatSystem, respiratory virus panel nucleic acid assay system, Material Number 07341920190DeviceClass II1
3 Sep 2021cobas EGFR Mutation Test v2-Somatic gene mutation detection system Catalog Number :07248563190DeviceClass II1
4 Aug 2021cobas SARS-CoV-2 & Influenza A/B Test for use on the cobas Liat System, Catalog Number 09211101190DeviceClass II1
25 Mar 2021cobas SARS-CoV-2 & Influenza A/B assay cobas Liat- Reagents, 2019-Novel Coronavirus Nucleic Acid for use on the cobas LiDeviceClass II2
23 Nov 2020uPath software 1.1 and uPath software 1.1 IVD-INSW, Material numbers 08991871001 and 09077332001DeviceClass II1
3 Jun 2020MagNA Pure 96 Instrument, clinical sample concentrator, Material number 06541089001 - Product Usage: This protocol is inDeviceClass II1
2 May 2018MagNA Pure 24 System, GMMI: 07290519001 Product Usage: The MagNA Pure 24 System is a fully automated clinical sample extDeviceClass II1
27 Oct 2017Nucleic Acid test intended for screening for MRSA/SA. Each kit has 20 tubes. in vitro diagnostic.DeviceClass II1

All 30 events for Roche Molecular Systems, Inc.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Dirty Lens May Cause Invalid or False Positive Results"

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide distribution - US Nationwide distribution and the countries of Canada, Germany, Italy, Spain, United Kingdom, France, Austria, Turkey, Belgium, Poland, Portugal, Greece, Netherlands,…"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 10 Aug 2023. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.